CA2017315A1 - Inhibiteur de l'interleukine i - Google Patents
Inhibiteur de l'interleukine iInfo
- Publication number
- CA2017315A1 CA2017315A1 CA2017315A CA2017315A CA2017315A1 CA 2017315 A1 CA2017315 A1 CA 2017315A1 CA 2017315 A CA2017315 A CA 2017315A CA 2017315 A CA2017315 A CA 2017315A CA 2017315 A1 CA2017315 A1 CA 2017315A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- interleukin
- inhibitor
- directed
- immunosuppression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35433089A | 1989-05-19 | 1989-05-19 | |
US07/354,330 | 1989-05-19 | ||
US50899990A | 1990-04-12 | 1990-04-12 | |
US07/508,999 | 1990-04-12 | ||
US52527490A | 1990-05-17 | 1990-05-17 | |
US07/525,274 | 1990-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2017315A1 true CA2017315A1 (fr) | 1990-11-19 |
CA2017315C CA2017315C (fr) | 2000-07-18 |
Family
ID=27408176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002017315A Expired - Fee Related CA2017315C (fr) | 1989-05-19 | 1990-05-22 | Inhibiteur de l'interleukine i |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0398817B1 (fr) |
JP (1) | JP2863265B2 (fr) |
AT (1) | ATE125571T1 (fr) |
CA (1) | CA2017315C (fr) |
DE (1) | DE69021128T2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
AU649245B2 (en) * | 1990-04-02 | 1994-05-19 | Amgen, Inc. | Methods for treating interleukin-1 mediated diseases |
DE4106570A1 (de) * | 1991-03-01 | 1992-09-03 | Max Planck Gesellschaft | Neue inhibitoren der endothelzell-proliferation |
HUP9900169A2 (hu) * | 1995-09-13 | 2000-03-28 | Takeda Chemical Industries, Ltd. | Immunoszuppresszáns hatású kinolin- vagy kinozalinszármazékok és ezeket tartalmazó gyógyászati készítmények |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US20030099650A1 (en) * | 2001-07-25 | 2003-05-29 | Ho Alice Suk-Yue | Treatment of immune disorders and B cell disorders |
-
1990
- 1990-05-19 JP JP2130125A patent/JP2863265B2/ja not_active Expired - Fee Related
- 1990-05-21 AT AT90401343T patent/ATE125571T1/de not_active IP Right Cessation
- 1990-05-21 EP EP90401343A patent/EP0398817B1/fr not_active Expired - Lifetime
- 1990-05-21 DE DE69021128T patent/DE69021128T2/de not_active Expired - Fee Related
- 1990-05-22 CA CA002017315A patent/CA2017315C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69021128D1 (de) | 1995-08-31 |
EP0398817A1 (fr) | 1990-11-22 |
ATE125571T1 (de) | 1995-08-15 |
JPH03128397A (ja) | 1991-05-31 |
CA2017315C (fr) | 2000-07-18 |
EP0398817B1 (fr) | 1995-07-26 |
JP2863265B2 (ja) | 1999-03-03 |
DE69021128T2 (de) | 1996-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5514190A (en) | Tumor necrosis factor binding protein II, it's purification and antibodies thereto | |
EP0625991A4 (fr) | Composition amelioree d'alpha interferon et procede de preparation a partir de leucocytes peripheriques humains. | |
MX9707732A (es) | Compuestos triciclicos utiles en el tratamiento de desordenes proliferativos de celulas. | |
MY106272A (en) | Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants. | |
CY1107495T1 (el) | Χρηση παραγωγων τετρακυκλινης για να αυξανεται παραγωγη ιντepλευκινης-10 | |
PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
MY121294A (en) | Novel hexanoic acid derivatives. | |
ES8603271A1 (es) | Un metodo de producir una composicion de interleuquina-2 | |
AU1373499A (en) | Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease | |
IT8848329A0 (it) | Trattamento batterico di conservazione della qualita' del fieno tramite aggiunta di microorganismi del genere bacillus | |
GB8806892D0 (en) | Lactams their synthesis & use in cosmetic compositions | |
UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
ES2151607T3 (es) | Factor 12 de crecimiento y de diferenciacion. | |
CA2017315A1 (fr) | Inhibiteur de l'interleukine i | |
ZA898605B (en) | Compositions for topical treatment of skin diseases | |
EP0736600A3 (fr) | Utilisation d'une lymphokine à activité suppressive de virus immunodéficient (ISL) pour inhiber la réplication de virus en particulier de rétrovirus | |
CA2227533A1 (fr) | Agents therapeutiques ameliores | |
EP0373540A3 (fr) | Méthode pour purifier des facteurs de croissance protéiques de fibroblastes | |
MY104070A (en) | Cyclopropane derivatives | |
EP0348290A3 (fr) | Monocytes tueurs activés : activité tumoricide et méthode pour leur contrôle | |
GR3015470T3 (en) | Inhibitors of lysyl oxidase. | |
CA2099497A1 (fr) | Peptides possedant une activite anticoagulante | |
EP0248217A3 (en) | Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor | |
AU7336687A (en) | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon | |
NZ310366A (en) | Haemopoietic growth factor antagonists and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKLA | Lapsed |
Effective date: 20040525 |